星宇控股(02346.HK)盈警:預計中期淨利約250萬元
格隆匯8月24日丨星宇控股(02346.HK)發佈公吿,預計集團截至2021年6月30日止六個月將錄得公司股東應占溢利淨額約人民幣250萬元(上年同期:溢利淨額約人民幣4700萬元)。
公吿稱,該預期溢利大幅減少主要由於該期間未收到政府補助及出售物業、廠房及設備和投資物業的收益並確認為其他收入。去年同期,政府補助約人民幣1900萬元及出售物業、廠房及設備和投資物業的收益約人民幣2820萬元計入其他收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.